Advent Life Sciences

What they do

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences, principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

What they look for

Advent Life Sciences focuses on backing exceptional innovation early to turn breakthrough science into approved medicines or medical products. They explicitly seek out companies with a "first-in-class" or "best-in-class" approach to addressing unmet medical needs.

Stage

Pre-seed, Seed, Series A, Series B+

Sectors

Healthcare, Deeptech

Based

London, GB